These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Human proadrenomedullin N-terminal 20 peptide in pheochromocytoma and normal adrenal medulla. Kuwasako K, Kitamura K, Ichiki Y, Kato J, Kangawa K, Matsuo H, Eto T. Biochem Biophys Res Commun; 1995 Jun 15; 211(2):694-9. PubMed ID: 7794284 [Abstract] [Full Text] [Related]
5. [Adrenomedullin and related peptides]. Kitamura K. Nihon Yakurigaku Zasshi; 1998 Sep 15; 112(3):137-46. PubMed ID: 9793067 [Abstract] [Full Text] [Related]
6. Distribution and characterization of rat immunoreactive proadrenomedullin N-terminal 20 peptide (PAMP) and the augmented cardiac PAMP in spontaneously hypertensive rat. Inatsu H, Sakata J, Shimokubo T, Kitani M, Nishizono M, Washimine H, Kitamura K, Kangawa K, Matsuo H, Eto T. Biochem Mol Biol Int; 1996 Feb 15; 38(2):365-72. PubMed ID: 8850532 [Abstract] [Full Text] [Related]
7. Decrease of TSH levels and epithelium/colloid ratio in rat thyroid glands following administration of proadrenomedullin N-terminal peptide (12-20). Ginda WJ, Nowak KW, Malendowicz LK. Horm Metab Res; 2000 Jan 15; 32(1):10-4. PubMed ID: 10727007 [Abstract] [Full Text] [Related]
8. [Adrenomedullin]. Bełtowski J. Postepy Hig Med Dosw; 1999 Jan 15; 53(1):99-123. PubMed ID: 10352550 [Abstract] [Full Text] [Related]
18. Specific binding sites for proadrenomedullin N-terminal 20 peptide (PAMP) in the rat. Iwasaki H, Hirata Y, Iwashina M, Sato K, Marumo F. Endocrinology; 1996 Jul 15; 137(7):3045-50. PubMed ID: 8770930 [Abstract] [Full Text] [Related]
20. Differential hormonal profiles of adrenomedullin and proadrenomedullin N-terminal 20 peptide in patients with heart failure and effect of treatment on their plasma levels. Etoh T, Kato J, Takenaga M, Imamura T, Kitamura K, Koiwaya Y, Eto T. Clin Cardiol; 1999 Feb 15; 22(2):113-7. PubMed ID: 10068849 [Abstract] [Full Text] [Related] Page: [Next] [New Search]